© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • China has announced a series of tax incentives to help boost demand for the non-existent Chinese Depository Receipt (CDR) market. But the authorities have it backwards, investors are available, finding a willing issuer is the problem.
  • Biopharmaceutical company Hutchison China MediTech (Chi-Med) is planning a Hong Kong IPO of around $500m, having filed a draft prospectus with the city’s stock exchange on Monday.
  • Over €6bn of new IPO paper was priced in Europe last week, the best single week of issuance in over four years.
  • Shares in Stadler Rail, the Swiss maker of rolling stock, gained as much as 12.9% in trading on Friday after it priced its Sfr1.33bn IPO at a discount to its Swiss industrial peers.
  • Hansoh Pharmaceutical Group has refiled its long-anticipated Hong Kong IPO. The Chinese drug maker first planned to go public in 2016, and was said to be readying a roadshow for its IPO as recently as February.
  • Primary EM equity capital markets IPOs are back in vogue, riding the momentum of secondary equity EM indices. With investors clamouring for alpha, Middle Eastern and African IPO issuers are lining up to test the appetite for new deals.